Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03524729
Other study ID # F2278-R
Secondary ID RX002278
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date June 1, 2023

Study information

Verified date June 2022
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ankle osteoarthritis (OA) is a painful, progressive condition that can severely limit physical activity and reduce quality of life. Rocker bottom (RB) shoes and ankle-foot orthoses (AFOs) are commonly used as non-surgical treatments for ankle OA. RB shoes have a curved sole in the toe to heel direction that may alleviate joint pain by reducing ankle range of motion (ROM). Similarly, AFOs may reduce joint motion by securing the foot and ankle within the ankle-foot orthosis (AFO) frame. This study aims to determine the ability of RB shoes and AFOs to improve mobility, by relieving pain and reducing joint ROM.


Description:

The investigators' objective is to compare two non-surgical treatments (RB shoes and Toeoff brand AFOs) in OA subjects by measuring their mobility and pain during and after a multi-week trial period. The investigators will use a biplane fluoroscopy system to measure foot joint motion for each condition (RB shoe, AFO, control shoe). This will yield clinical and biomechanical measures of the effect of each orthotic on mobility, pain, and joint ROM in an ankle OA population. The investigators will also compare the clinical and biomechanics outcomes of OA subjects to those of control subjects. This information will provide evidence to support clinical decision making. Aim 1: Compare the daily sep count, self-selected walking speed, clinical outcome measures (PROMIS surveys) of a control shoe, RB shoe, and AFO worn over a multi-week trial period. Aim 2: Evaluate the effect of a control shoe, RB shoe, and AFO on the foot and ankle joints range of motion. Aim 3: Compare the ankle OA clinical and biomechanical outcome measures for the control shoe, RB shoe, and AFO to a healthy control group wearing control shoes. The efficacy of conservative treatments such as RB shoes and AFOs for managing OA pain and discomfort is not well supported by clinical evidence. By using biplane fluoroscopy along with validated clinical measures of pain and mobility, this study will elucidate the mechanism by which RB shoes and AFOs biomechanically alter foot and ankle function. Identifying beneficial treatment strategies for people with ankle OA will help them regain their mobility and improve their quality of life.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 11
Est. completion date June 1, 2023
Est. primary completion date June 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: For osteoarthritis patients: - radiographic evidence of tibiotalar osteoarthritis - ambulatory For healthy controls: - ambulatory - aged 18 or older Exclusion Criteria: For osteoarthritis patients and healthy controls: - subtalar joint arthritis - plans for surgical treatment of ankle osteoarthritis within the next 4 months - surgical, neurological, metabolic, or lower limb musculoskeletal problem that would impair study measures - inability to walk unassisted during short, repeated walking trials - rheumatoid arthritis - inadequate cognitive or language function to consent or to participate - no phone number or stable mailing address

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Rocker bottom shoe
Walking shoe with a anterior posterior rocker sole.
Ankle foot orthosis
Dynamic carbon fiber ankle brace.
Standard walking shoe
Standard walking shoe (control shoe) with no rocker sole.

Locations

Country Name City State
United States VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Daily step count (# steps) The daily step count of a participant as measured by a body worn pedometer. Three weeks
Secondary Ankle joint range of motion (degrees) Range of motion of the ankle joint in degrees as measured by biplane fluoroscopy and/ or CT scan Three weeks
Secondary Self-selected walking speed Self-selected walking speed as measured with a stop watch when walking a fixed distance. Three weeks
Secondary Qualitative assessment of patient device wearing Would you continue to wear the device if you were not part of the study? Why/why not? Three weeks
Secondary PROMIS physical function Self reported capability of physical function three weeks
Secondary PROMIS pain interference Self reported consequences of pain on relevant aspects of one's life. Three weeks
Secondary Foot and ankle Mobility measure FAAM American Academy of Orthopaedic Surgeons Foot and Ankle Module questionnaire designed to assess foot and ankle conditions. Three weeks
Secondary Numeric Pain Rating Scale The Numeric Pain Rating Scale is a measure of pain intensity in adults in which the respondent selects a whole number (0-10) that best reflects the intensity of her / his pain. The scale will be administered verbally. Three weeks
Secondary Fast walking speed Fast walking speed as measured with a stop watch when walking a fixed distance. Three weeks
Secondary Timed-up-and-go Self-selected walking speed get out of a chair, walk to a line, turn around, walk back to the chair and sit down as measured with a stop watch. Three weeks
Secondary Qualitative assessment of patient satisfaction with the device Do you like the device? Why/why not? Three weeks
Secondary Qualitative assessment of device preference Do you have a preference to one of the treatments? Which one? Why/why not? Three Months
See also
  Status Clinical Trial Phase
Completed NCT02508233 - Cross-cultural Adaptation and Validation of the Ankle Osteoarthritis Scale (AOS) for Use in French-speaking Populations N/A
Completed NCT01504438 - Prospective Randomized Evaluation of a Two and Three Piece Total Ankle Replacement N/A
Active, not recruiting NCT03440008 - Improving the Detection, Classification and Treatment of Misaligned Arthritic Ankles
Active, not recruiting NCT06404801 - Development of Stance Control Orthotic Knee Joint For Improvement of KAFO Users
Active, not recruiting NCT04405297 - A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
Completed NCT01760577 - Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis N/A
Active, not recruiting NCT04998162 - Injections of SVF in Ankle Osteoarthritis N/A
Completed NCT03356951 - Gait Analysis Following Total Ankle Replacement and Subtalar Fusion N/A
Completed NCT02489188 - Gait Asymmetry Assessed Using Portable Gait Analysis System
Completed NCT01986244 - Total Ankle Replacement for Ankle Arthritis
Withdrawn NCT05562154 - Lateral Approach Versus Anterior Approach in Total Ankle Replacement N/A
Completed NCT03567187 - Cryoneurolysis for Improvements in Pain, ADL and QOL in Patients With Ankle Osteoarthritis N/A
Completed NCT05868759 - Assessment of Preoperative and Postoperative Ankle Kinematics N/A
Recruiting NCT06193057 - Comparison of Customized and Standard Total Ankle Prostheses N/A
Recruiting NCT06028763 - Development of Biomedical Technology for the Treatment of Ankle Cartilage Using Injectable Biocomposite Hydrogel N/A
Not yet recruiting NCT03573245 - Tranexamic Acid in Major Orthopedic Surgery: Comparison of 3 Dosage Regimen
Completed NCT04022928 - A Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle OA N/A
Completed NCT02629731 - Orthotic Dose Response Study N/A
Recruiting NCT03157141 - Ankle Osteoarthritis N/A
Completed NCT03711747 - Indications for Osteochondral Allograft Transplantation